Emerging roles of ferroptosis in cardiovascular diseases

Kai Wang1, Xin-Zhe Chen1, Yun-Hong Wang2

  • 1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, 266073, Shandong, China.

Cell Death Discovery
|September 20, 2022
PubMed

Insights

Ferroptosis, a novel cell death pathway, is implicated in cardiovascular diseases (CVDs). Understanding ferroptosis mechanisms offers potential new therapeutic strategies for treating CVDs.

Area of Science:

  • Biomedical Science
  • Cardiovascular Research
  • Cell Death Mechanisms

Background:

  • Cardiovascular diseases (CVDs) pose a significant global health threat.
  • Cardiomyocyte death is a key factor in CVD development.
  • Ferroptosis, a novel iron-dependent programmed cell death, involves lipid peroxidation and ROS accumulation.

Purpose of the Study:

  • To review the characteristics and mechanisms of ferroptosis.
  • To explore the role of ferroptosis in the pathophysiology of CVDs.
  • To identify ferroptosis as a potential therapeutic target for CVDs.

Main Methods:

  • Literature review of ferroptosis and cardiovascular disease research.
  • Analysis of studies investigating ferroptosis inducers and inhibitors.
  • Synthesis of current understanding of ferroptosis pathways.

Main Results:

  • Ferroptosis is mechanistically distinct from other cell death types (apoptosis, necrosis, etc.).
  • Ferroptosis is increasingly recognized as a contributor to various CVDs.
  • Compounds regulating ferroptosis show therapeutic potential.

Conclusions:

  • Ferroptosis plays a critical role in cardiovascular disease progression.
  • Targeting ferroptosis pathways presents a promising avenue for novel CVD treatments.
  • Further research into ferroptosis mechanisms can guide therapeutic development for CVDs.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.7K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
783
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
25
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K